Sylwia Figarska


Sylwia received her MS degree in biology from University of Lodz, Poland (2009) and PhD in medical sciences from Rijksuniversiteit Groningen (2014). During her PhD project focused on genetic factors contributing to human aging, Sylwia visited Mayo Clinic (Rochester, MN) to study senescence of human adipose tissue. As a postdoctoral researcher at Johannes Gutenberg University Mainz, Germany (2014-2016) she analyzed ancient human genomes. During  her second postdoctoral project, in the Prof. Erik Ingelsson’s  group at Stanford University (2016-2019) she studied genetics and proteomics of obesity, insulin resistance,  and cardiovascular disease to discover novel targets for drug development.

Contact details

Current activities

As a bioinformatician in the group of Prof. Adriaan Voors,  I am analyzing clinical and multi -omics data sets  with the aim of improving clinical outcome of patients with heart failure.

My projects


Facilitate personalized therapies in patients with heart failure

My publications

Dyspnea severity, changes in dyspnea status and mortality in the general population: the Vlagtwedde/Vlaardingen study.

Figarska SM, Boezen HM, Vonk JM. Eur J Epidemiol. 2012

view on publisher site

SIRT1 polymorphism, long-term survival and glucose tolerance in the general population.

Figarska SM, Vonk JM, Boezen HM. PLoS One. 2013

view on PubMed

Associations of Circulating Protein Levels With Lipid Fractions in the General Population.

Figarska SM, Gustafsson S, Sundström J, Ärnlöv J, Mälarstig A, Elmståhl S, Fall T, Lind L, Ingelsson E. Arterioscler Thromb Vasc Biol. 2018

view on publisher site